Results 231 to 240 of about 92,349 (287)
The impact of immature granulocytes on the outcome of patients with decompensated cirrhosis
Immature granulocyte (IG) count and percentage had a predictive role in patients with decompensated cirrhosis, making them an objective and easily available marker of prognosis for this group of patients. In addition, IG percentage was the only factor independently associated with transplant‐free survival.
Magdalini Adamantou+10 more
wiley +1 more source
Houston, we have a problem: Coagulation concerns during long‐term spaceflight
Experimental Physiology, EarlyView.
Lewis Fall, Damian M. Bailey
wiley +1 more source
ABSTRACT Objective To report data from an ITI chart review study (NCT03951103) for first‐time and rescue ITI with recombinant factor VIII Fc fusion protein (rFVIIIFc) in persons with haemophilia A. Methods Retrospective and prospective real‐world data are reported from a non‐interventional, multicentre study of patients who had been or were currently ...
Robert Klamroth+7 more
wiley +1 more source
Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries. [PDF]
Wang HS+5 more
europepmc +1 more source
Prothrombin Time (PT) for Human Plasma on QCM-D Platform: A Better Alternative to 'Gold Standard'
Munawar Hussain
openalex +1 more source
Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific
ABSTRACT Introduction Activated protein C resistance (APCR) represents a risk factor for thrombosis and is usually due to factor V Leiden (FVL). Clinicians may order either test (i.e., APCR or FVL) to help assess ‘thrombophilia’ in patients who present with thrombosis. APCR testing is usually achieved using clot‐based assays, whereas FVL is assessed by
Emmanuel J. Favaloro+8 more
wiley +1 more source
Opportunities to improve surveillance of hepatocellular carcinoma in Australia
Medical Journal of Australia, EarlyView.
Jess Howell+10 more
wiley +1 more source
Surface Engineering of Thrombus‐Targeting Nanocarriers for Cardiovascular Diseases: A Short Review
This paper systematically introduces surface modification strategies for thrombus‐targeting nanocarriers, highlights the clinical significance of nanocarrier‐based thrombolysis therapies, and prospects the synergy of combing thrombolysis and anti‐inflammatory therapies for enhanced therapeutic effect.
Xinyue Ge+7 more
wiley +1 more source